Entry |
|
Name |
Smith-Lemli-Opitz syndrome |
Description |
Smith-Lemli-Opitz syndrome is an autosomal recessive disorder caused by deficiency of 7-dehydrocholesterol reductase in cholesterol biosynthesis.
|
Category |
Inherited metabolic disorder
|
Brite |
Human diseases in ICD-11 classification [BR:br08403]
05 Endocrine, nutritional or metabolic diseases
Metabolic disorders
Inborn errors of metabolism
5C52 Inborn errors of lipid metabolism
H00161 Smith-Lemli-Opitz syndrome
Pathway-based classification of diseases [BR:br08402]
Lipid/glycolipid metabolism
nt06034 Cholesterol biosynthesis
H00161 Smith-Lemli-Opitz syndrome
|
Pathway |
|
Network |
|
Gene |
|
Other DBs |
|
Reference |
|
Authors |
Porter FD |
Title |
Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. |
Journal |
|
Reference |
|
Authors |
Yu H, Patel SB |
Title |
Recent insights into the Smith-Lemli-Opitz syndrome. |
Journal |
|
Reference |
|
Authors |
Correa-Cerro LS, Porter FD |
Title |
3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. |
Journal |
|
Reference |
|
Authors |
Wassif CA, Maslen C, Kachilele-Linjewile S, Lin D, Linck LM, Connor WE, Steiner RD, Porter FD |
Title |
Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. |
Journal |
|
LinkDB |
|